Safety profile of live varicella virus vaccine (Oka/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP). (Q45374786)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 June 2010

Language	Label	Description	Also known as
English	Safety profile of live varicella virus vaccine (Oka/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP).	scientific article published on 30 June 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Safety profile of live varicella virus vaccine (Oka/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP). (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

author name string

Nicolas Goulleret

1

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Elodie Mauvisseau

2

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Mélanie Essevaz-Roulet

3

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Mark Quinlivan

4

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

language of work or name

0 references

publication date

30 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

36

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

5878-5882

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.056

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.056

7 January 2021

The safety profile of varicella vaccine: a 10-year review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.056

7 January 2021

The postmarketing safety profile of varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.056

7 January 2021

Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.056

7 January 2021

Natural selection for rash-forming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.056

7 January 2021

Phylogenetic analysis of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.056

7 January 2021

Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.056

7 January 2021

Analysis of United Kingdom wild-type strains of varicella-zoster virus: differentiation from the Oka vaccine strain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.056

7 January 2021

Identification of five major and two minor genotypes of varicella-zoster virus strains: a practical two-amplicon approach used to genotype clinical isolates in Australia and New Zealand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.056

7 January 2021

A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24-25 July 2008.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.056

7 January 2021

A case of varicella caused by co-infection with two different genotypes of varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.056

7 January 2021

Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.056

7 January 2021

Herpes zoster and meningitis resulting from reactivation of varicella vaccine virus in an immunocompetent child

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.056

7 January 2021

The out of Africa model of varicella-zoster virus evolution: single nucleotide polymorphisms and private alleles distinguish Asian clades from European/North American clades

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.056

7 January 2021

Genetic variation of varicella-zoster virus: evidence for geographical separation of strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.056

7 January 2021

Distribution of varicella-zoster virus (VZV) wild-type genotypes in northern and southern Europe: evidence for high conservation of circulating genotypes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.06.056

7 January 2021

Identifiers

10.1016/J.VACCINE.2010.06.056

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45374786&oldid=1775329512"